Aegis Agents connect with CRONOS—and, where technically validated, with other clinical systems and data sources—so CRO, Pharma and Biotech teams can move from fragmented operational signals to controlled, evidence-based oversight.
CRONOS keeps clinical operations controlled. Aegis Agents turn signals from CRONOS, other systems and source data into prioritised review, earlier risk visibility and clearer database-lock readiness.
Run the operating workflows behind Late Phase trials and BA/BE & Early Phase studies in a purpose-built clinical platform.
Bring multi-source study signals, review priorities and risk into one controlled view so experts can focus attention where it matters most.
WHPL shapes the first conversation around the workflow, team and decision pressure you are managing today.
Streamline intensive study conduct, sample and data workflows, review load and the path to database lock.
Explore the CRO path →Connect fragmented systems, reduce manual review and strengthen central monitoring across a growing study portfolio.
Explore the CRO path →Focus on the study-control problem where review burden, risk visibility or oversight urgency creates the greatest impact.
Explore the sponsor path →Bring us the workflow creating the most delay, review burden or risk. Together, we will map a focused starting point and define the operational outcomes that matter.